Heidi Cuthbert

Bitmine Immersion slowed its Ethereum accumulation strategy last week, purchasing 26,497 ETH worth approximately $53 million as it moves closer to its long-term ownership target.

Legend Biotech (NASDAQ:LEGN) presented first-in-human clinical data for its investigational solid tumor therapy alongside long-term tracking metrics for its commercially approved blood cancer asset at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

US Senator Cynthia Lummis has warned that Congress could miss a critical opportunity to establish comprehensive cryptocurrency legislation, potentially delaying major regulatory reforms until 2030.

Rallybio (NASDAQ:RLYB) and Avenzo Therapeutics announced Monday that they have entered into a definitive agreement to combine through a merger transaction.

XRP Ledger recorded strong growth in network activity and tokenisation during the first quarter of 2026, but XRP fell 27.1% over the same period and ended May down a further 6.19%.

Kamada (NASDAQ:KMDA) announced Monday that the U.S. Food and Drug Administration has approved its new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) rabies virus neutralization laboratory at its manufacturing plant in Beit Kama, Israel.

Invivyd (NASDAQ:IVVD) completed enrollment for the pivotal Phase 3 clinical trial of its leading monoclonal antibody candidate, positioning the biotechnology firm to deliver late-stage results later this quarter.

The Cardano Foundation has cancelled its 2026 annual conference after the community rejected a proposal to fund the event using treasury assets for a second time.

FedEx (NYSE:FDX) completed the separation of its less-than-truckload operational unit on Monday, launching FedEx Freight Holding Company (NYSE:FDXF) as an independent, publicly traded entity on the New York Stock Exchange.

Hyperliquid’s HYPE token rose to a new record high after breaking above $70 and touching $74.04 during its latest rally.